Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The laboratory of Dr. Gavin Ha (https://gavinhalab.org) has a Post-Doctoral Research Fellow position open in the Herbold Computational Biology Program of the Public Health Sciences and Human Biology Divisions. We are seeking a highly motivated individual who will bring a deep understanding of cancer biology to our computational team. Candidates who are excited about new laboratory and computational methods to study large/complex ‘omics’ data of cancer genomes and liquid biopsy research are encouraged to apply. The position has a competitive salary and great benefits.
The Ha Lab develops computational approaches to study cancer genomes from tumors and liquid biopsies, such as circulating tumor DNA. Their goals are to uncover mechanisms of treatment resistance, to identify blood-based genetic biomarkers, and to translate these findings to help improve clinical applications. The lab is supported by the National Institutes of Health (NIH) and DoD/CDMRP, including receiving funding from the NIH Director’s New Innovator Award, the Prostate Cancer Foundation, and the V Foundation.
We work in an interdisciplinary team environment with many local and external experts. All our projects involve partnering with investigators who have diverse expertise in molecular and experimental biology, cancer biology, and clinical research. The successful candidate will have the opportunity to work on transformative and leading-edge research problems in cancer research:
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
To apply, please submit your application with the following:
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
The annual base salary range for this position is from $67,728 to $150,000 and pay offered will be based on experience and qualifications. This position may be eligible for relocation assistance.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, income-based child care subsidy, tuition reimbursement, paid vacation (22 days per year), paid sick leave (up to 30 calendar days per occurrence of a qualifying reason), paid holidays (13 days per year), and paid parental leave (up to 4 weeks).
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide.
An independent, nonprofit organization, Fred Hutch also serves as UW Medicine’s cancer program. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Fred Hutchinson Cancer Center will accelerate the development, evaluation, and use of new cancer discoveries and treatments and will offer patients greater access to clinical trials, bringing research and clinical care closer together. For current patients the superior care you have come to expect from us will continue uninterrupted. For example, as part of the transition to Fred Hutch there will be no changes to your doctor or care team. Over the longer term, this update to our structure will enable us to improve patients’ care experiences and increase integration across your care team.
Fred Hutch will focus on integrating teams and operations over the coming weeks and months but you will see some new changes coming soon.
During the transition and afterward, high-quality patient care, research and operations will continue uninterrupted. Seattle Children's, an original SCCA alliance partner, will work in close partnership with Fred Hutchinson Cancer Center to advance breakthroughs in adult and pediatric oncology.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Learn more about UW Medicine
Learn more about our research at Fred Hutch